Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,516 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.
Inoue Y, Trapnell BC, Tazawa R, Arai T, Takada T, Hizawa N, Kasahara Y, Tatsumi K, Hojo M, Ichiwata T, Tanaka N, Yamaguchi E, Eda R, Oishi K, Tsuchihashi Y, Kaneko C, Nukiwa T, Sakatani M, Krischer JP, Nakata K; Japanese Center of the Rare Lung Diseases Consortium. Inoue Y, et al. Among authors: takada t. Am J Respir Crit Care Med. 2008 Apr 1;177(7):752-62. doi: 10.1164/rccm.200708-1271OC. Epub 2008 Jan 17. Am J Respir Crit Care Med. 2008. PMID: 18202348 Free PMC article.
Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis.
Tazawa R, Trapnell BC, Inoue Y, Arai T, Takada T, Nasuhara Y, Hizawa N, Kasahara Y, Tatsumi K, Hojo M, Ishii H, Yokoba M, Tanaka N, Yamaguchi E, Eda R, Tsuchihashi Y, Morimoto K, Akira M, Terada M, Otsuka J, Ebina M, Kaneko C, Nukiwa T, Krischer JP, Akazawa K, Nakata K. Tazawa R, et al. Among authors: takada t. Am J Respir Crit Care Med. 2010 Jun 15;181(12):1345-54. doi: 10.1164/rccm.200906-0978OC. Epub 2010 Feb 18. Am J Respir Crit Care Med. 2010. PMID: 20167854 Free PMC article. Clinical Trial.
Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan.
Ishii H, Tazawa R, Kaneko C, Saraya T, Inoue Y, Hamano E, Kogure Y, Tomii K, Terada M, Takada T, Hojo M, Nishida A, Ichiwata T, Trapnell BC, Goto H, Nakata K. Ishii H, et al. Among authors: takada t. Eur Respir J. 2011 Feb;37(2):465-8. doi: 10.1183/09031936.00092910. Eur Respir J. 2011. PMID: 21282812 Free article. No abstract available.
Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
Ohashi K, Sato A, Takada T, Arai T, Nei T, Kasahara Y, Motoi N, Hojo M, Urano S, Ishii H, Yokoba M, Eda R, Nakayama H, Nasuhara Y, Tsuchihashi Y, Kaneko C, Kanazawa H, Ebina M, Yamaguchi E, Kirchner J, Inoue Y, Nakata K, Tazawa R. Ohashi K, et al. Among authors: takada t. Respir Med. 2012 Feb;106(2):284-93. doi: 10.1016/j.rmed.2011.10.019. Epub 2011 Nov 22. Respir Med. 2012. PMID: 22112784 Free article.
Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis.
Ohashi K, Sato A, Takada T, Arai T, Kasahara Y, Hojo M, Nei T, Nakayama H, Motoi N, Urano S, Eda R, Yokoba M, Tsuchihashi Y, Nasuhara Y, Ishii H, Ebina M, Yamaguchi E, Inoue Y, Nakata K, Tazawa R. Ohashi K, et al. Among authors: takada t. Eur Respir J. 2012 Mar;39(3):777-80. doi: 10.1183/09031936.00076711. Eur Respir J. 2012. PMID: 22379153 Free article. No abstract available.
Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapy.
Tazawa R, Inoue Y, Arai T, Takada T, Kasahara Y, Hojo M, Ohkouchi S, Tsuchihashi Y, Yokoba M, Eda R, Nakayama H, Ishii H, Nei T, Morimoto K, Nasuhara Y, Ebina M, Akira M, Ichiwata T, Tatsumi K, Yamaguchi E, Nakata K. Tazawa R, et al. Among authors: takada t. Chest. 2014 Apr;145(4):729-737. doi: 10.1378/chest.13-0603. Chest. 2014. PMID: 24158247 Clinical Trial.
1,516 results